TGF-β1 protein was ~3x higher in orthotopically-implanted tumors from 4T1 and F311 breast cancer models (BALB/c strain), and ~8x higher in MVT1 tumors (FVB/N strain) when compared to the normal mammary gland of the matched strain. Here, TGFB1 is linked to breast carcinoma.